Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.

• Main Authors: Francisca Mutapi (Author), Nadine Rujeni (Author), Claire Bourke (Author), Kate Mitchell (Author), Laura Appleby (Author), Norman Nausch (Author), Nicholas Midzi (Author), Takafira Mduluza (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2011-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Morbidity due to schistosomiasis is currently controlled by treatment of schistosome infected people with the antihelminthic drug praziquantel (PZQ). Children aged up to 5 years are currently excluded from schistosome control programmes largely due to the lack of PZQ safety data in this age group. T...